研究
教育
解決策
サインイン
JA
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Inst. of Neuroscience and Physiology,
Dept. of Psychiatry and Neurochemistry,
Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry
Johan Gobom has not added Biography.
If you are Johan Gobom and would like to personalize this page please email our Author Liaison for assistance.
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.
Brain research Nov, 2010 | Pubmed ID: 20875798
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
Journal of mass spectrometry : JMS May, 2012 | Pubmed ID: 22576872
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
PloS one , 2012 | Pubmed ID: 22880031
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917143
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Alzheimer's research & therapy , 2016 | Pubmed ID: 26948580
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
Journal of neurochemistry Aug, 2016 | Pubmed ID: 27579672
Expanding the cerebrospinal fluid endopeptidome.
Proteomics Mar, 2017 | Pubmed ID: 28044435
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.
Molecular neurodegeneration Feb, 2017 | Pubmed ID: 28219449
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
Scientific reports Oct, 2017 | Pubmed ID: 29042634
Sahlgrenska Academy at University of Gothenburg
Sahlgrenska University Hospital
Karl T. Hansson1,
Tobias Skillbäck1,2,
Elin Pernevik1,
Jessica Holmén-Larsson1,
Gunnar Brinkmalm1,
Kaj Blennow1,2,
Henrik Zetterberg1,2,3,
Johan Gobom1,2
1Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg,
2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital,
3Department of Molecular Neuroscience, UCL Institute of Neurology
個人情報保護方針
利用規約
一般データ保護規則
お問い合わせ
図書館への推薦
JoVE ニュースレター
JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
著者
図書館員
アクセス
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved